戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 structural similarities and differences with anthrax lethal factor.
2 e 60-fold more toxic to mammalian cells than anthrax lethal factor.
3 ve been shown to act as potent inhibitors of anthrax lethal factor and may have potential application
4 y also inactivated the enzymatic activity of anthrax lethal factor and protected murine RAW-264.7 cel
5 holera toxin beta-subunit, diphtheria toxin, anthrax lethal factor and protective antigen, Staphyloco
6 fA is related to the catalytic domain of the anthrax lethal factor and the Mop protein involved in th
7 alogs to kill Staphylococcus aureus, inhibit anthrax lethal factor, and bind human immunodeficiency v
8 ied their killing of bacteria, inhibition of anthrax lethal factor, and binding to HIV-1 gp120.
9 n that is conserved in anthrax edema factor, anthrax lethal factor, and botulinum neurotoxin serotype
10 hemical library against protease activity of anthrax lethal factor, and report a compound that inhibi
11                                         Like anthrax lethal factor, Certhrax was found to require pro
12 , treatment with the MEK inhibitors U0126 or anthrax lethal factor delayed GVBD and prevented spindle
13   Certhrax shares 31% sequence identity with anthrax lethal factor from Bacillus anthracis; however,
14 inum neurotoxin (BoNT) serotypes A and B and anthrax lethal factor in the picomolar range was demonst
15                      Finally, the pathogen's anthrax lethal factor is required to establish lethal in
16  an anti-cancer fusion protein consisting of anthrax lethal factor (LF) and the catalytic domain of P
17                                              Anthrax lethal factor (LF) enters the cytosol through po
18 -aa polypeptide that facilitates the exit of anthrax lethal factor (LF) from the endosome to the cyto
19                                              Anthrax lethal factor (LF) is a critical virulence facto
20                                              Anthrax lethal factor (LF) is a key virulence factor of
21                                              Anthrax lethal factor (LF) is a Zn2+ -metalloprotease th
22                        The metalloproteinase anthrax lethal factor (LF) is secreted by Bacillus anthr
23                                              Anthrax lethal factor (LF) is then able to translocate t
24 series of compounds that efficiently inhibit anthrax lethal factor (LF) metallo-protease.
25 ensin RTD-1 is a noncompetitive inhibitor of anthrax lethal factor (LF) protease (IC50 = 390 +/- 20 n
26 ion of a cell-based fluorescent reporter for anthrax lethal factor (LF) protease activity using the p
27 s have also been evaluated for inhibition of anthrax lethal factor (LF), an unrelated metalloprotease
28            They bind protein toxins, such as anthrax lethal factor (LF), and kill bacteria, including
29                                              Anthrax lethal factor (LF), anti-protective antigen (ant
30 ly to its ability to kill S. aureus, inhibit anthrax lethal factor (LF), bind gp120 of HIV-1, dimeriz
31                                              Anthrax lethal factor (LF), secreted by Bacillus anthrac
32 98, George Vande Woude's lab discovered that anthrax lethal factor (LF), the principal virulence comp
33 LFN, the N-terminal PA binding domain of the anthrax lethal factor (LF).
34                                          The anthrax lethal factor metalloprotease and small-molecule
35                                A fragment of anthrax lethal factor possesses the interesting function
36 ains the first of the two cleavage sites for anthrax lethal factor protease that have been found in t
37 ication of this platform to detection of the anthrax lethal factor sequence.
38                                          LF (anthrax lethal factor), which cleaves certain MAP kinase